Some top doctors and hospital leaders have called on the government to change how it buys drugs for public hospitals. Read ...

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Dr. Reddy's Laboratories Limited RDY reported third-quarter fiscal 2025 earnings of 20 cents per American Depositary Share ...

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...

President Donald Trump rolled back a Biden administration executive order aimed at lowering prescription drug prices, including an effort to make more generic drugs available to Medicare patients for ...

A formulary is a list of prescription drugs that a particular insurance plan ... Many formularies include the generic form of a prescription but not the brand name. Other formularies might specify ...

Retail drugs that have no generic equivalent and have been on the ... the HIV medication Biktarvy and the cancer drug Xtandi. The list price on Merck's diabetes drug Janumet increased 293% since ...

The prescription drug costs bill requires insurance companies to eliminate cost-sharing requirements for one generic drug and to cap co-payments on one brand-name drug at $25 per 30-day supply for ...

and my main concern with this form of promotion is that it leads to a rapid and widespread escalation of the use of new drugs that are not necessarily better than similar generic drugs already in ...

saying the list of drugmakers conspired to overcharge the insurer, consumers and the federal government for generic drugs. The complaint (PDF), filed Dec. 31, claims the drugmakers communicated ...

The list price of Merck & Co.'s heavily discounted diabetes medications Januvia and Janumet will be lowered "to align the list price more closely to the net price. More drug price increases are likely ...